Discovery of Novel Small-Molecule Calcium Sensitizers for Cardiac Troponin C: A Combined Virtual and Experimental Screening Approach
暂无分享,去创建一个
Steffen Lindert | William H Coldren | Svetlana B Tikunova | Jonathan P Davis | Jonathan P. Davis | S. Lindert | S. Tikunova | William H. Coldren
[1] S. Lindert,et al. Molecular Dynamics and Umbrella Sampling Simulations Elucidate Differences in Troponin C Isoform and Mutant Hydrophobic Patch Exposure. , 2018, The journal of physical chemistry. B.
[2] Levi C. T. Pierce,et al. Dynamics and Calcium Association to the N-Terminal Regulatory Domain of Human Cardiac Troponin C: A Multiscale Computational Study , 2012, The journal of physical chemistry. B.
[3] Jonathan P. Davis,et al. Successful Identification of Cardiac Troponin Calcium Sensitizers Using a Combination of Virtual Screening and ROC Analysis of Known Troponin C Binders , 2017, J. Chem. Inf. Model..
[4] Jalal K. Siddiqui,et al. Myofilament Calcium Sensitivity: Consequences of the Effective Concentration of Troponin I , 2016, Front. Physiol..
[5] Matthew P. Repasky,et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.
[6] Rommie E. Amaro,et al. An improved relaxed complex scheme for receptor flexibility in computer-aided drug design , 2008, J. Comput. Aided Mol. Des..
[7] B. Sykes,et al. Structures reveal details of small molecule binding to cardiac troponin. , 2016, Journal of molecular and cellular cardiology.
[8] B. Sykes,et al. Structure of the Inhibitor W7 Bound to the Regulatory Domain of Cardiac Troponin C† , 2009, Biochemistry.
[9] Jalal K. Siddiqui,et al. Designing proteins to combat disease: Cardiac troponin C as an example. , 2016, Archives of biochemistry and biophysics.
[10] Svetlana B Tikunova,et al. Ca(2+) exchange with troponin C and cardiac muscle dynamics. , 2008, Cardiovascular research.
[11] R. Solaro,et al. Stimulation of Ca++ Binding and ATPase Activity of Dog Cardiac Myofibrils by AR‐L 115BS, a Novel Cardiotonic Agent , 1982, Circulation research.
[12] I. M. Robertson,et al. Probing the mechanism of cardiovascular drugs using a covalent levosimendan analog , 2016, Journal of molecular and cellular cardiology.
[13] Jennifer L. Knight,et al. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.
[14] Clint L. Miller,et al. Regulation of Phosphodiesterase 3 and Inducible cAMP Early Repressor in the Heart , 2007, Circulation research.
[15] K. Swedberg,et al. Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.
[16] Gordon M. Crippen,et al. Prediction of Physicochemical Parameters by Atomic Contributions , 1999, J. Chem. Inf. Comput. Sci..
[17] Brian D Sykes,et al. Structure of the Regulatory N-domain of Human Cardiac Troponin C in Complex with Human Cardiac Troponin I147–163 and Bepridil* , 2002, The Journal of Biological Chemistry.
[18] J. Papp,et al. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy. , 2016, European journal of pharmacology.
[19] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[20] A. McCulloch,et al. Molecular Effects of cTnC DCM Mutations on Calcium Sensitivity and Myofilament Activation-An Integrated Multiscale Modeling Study. , 2016, The journal of physical chemistry. B.
[21] Jung-Hsin Lin,et al. The relaxed complex method: Accommodating receptor flexibility for drug design with an improved scoring scheme. , 2003, Biopolymers.
[22] J. Mccammon,et al. Computer‐Aided Drug Discovery Approach Finds Calcium Sensitizer of Cardiac Troponin , 2015, Chemical biology & drug design.
[23] J. Chalovich,et al. A computational and experimental approach to investigate bepridil binding with cardiac troponin. , 2011, The journal of physical chemistry. B.
[24] S. Perrone,et al. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure. , 2005, International journal of cardiology.
[25] C. Simmerling,et al. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.
[26] B. Sykes,et al. Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C. , 1999, Biochemistry.
[27] Jonathan P. Davis,et al. Rationally engineered Troponin C modulates in vivo cardiac function and performance in health and disease , 2016, Nature Communications.
[28] M. Endoh,et al. A novel cardiotonic agent SCH00013 acts as a Ca++ sensitizer with no chronotropic activity in mammalian cardiac muscle. , 1998, The Journal of pharmacology and experimental therapeutics.
[29] J. Mccammon,et al. Computational drug design accommodating receptor flexibility: the relaxed complex scheme. , 2002, Journal of the American Chemical Society.
[30] Yuichiro Maéda,et al. Structure of the core domain of human cardiac troponin in the Ca2+-saturated form , 2003, Nature.
[31] J. Andrew McCammon,et al. Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation , 2015, Journal of chemical theory and computation.
[32] J. Johnson,et al. Stimulation of cardiac myofilament force, ATPase activity and troponin C Ca++ binding by bepridil. , 1986, The Journal of pharmacology and experimental therapeutics.
[33] Svetlana B Tikunova,et al. Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C. , 2007, Biophysical journal.
[34] D. Allen,et al. Calcium sensitisers. , 1990, BMJ.
[35] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[36] Luhua Lai,et al. Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..
[37] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[38] J. Levijoki,et al. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. , 1995, Journal of molecular and cellular cardiology.
[39] S. Perry. Troponin I: Inhibitor or facilitator , 2004, Molecular and Cellular Biochemistry.
[40] Ruth Huey,et al. Computational protein–ligand docking and virtual drug screening with the AutoDock suite , 2016, Nature Protocols.
[41] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[42] E. Homsher,et al. Skeletal and cardiac muscle contractile activation: tropomyosin "rocks and rolls". , 2001, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[43] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[44] Brian D Sykes,et al. Solution structure of the regulatory domain of human cardiac troponin C in complex with the switch region of cardiac troponin I and W7: the basis of W7 as an inhibitor of cardiac muscle contraction. , 2010, Journal of molecular and cellular cardiology.
[45] Steffen Lindert,et al. Mechanism of Cardiac Troponin C Calcium Sensitivity Modulation by Small Molecules Illuminated by Umbrella Sampling Simulations , 2019, J. Chem. Inf. Model..
[46] S. Lindert,et al. Computational Studies of Cardiac and Skeletal Troponin , 2019, Front. Mol. Biosci..
[47] Jeremy R. Greenwood,et al. Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..
[48] Jonathan P. Davis,et al. 3-Chlorodiphenylamine activates cardiac troponin by a mechanism distinct from bepridil or TFP , 2018, The Journal of general physiology.
[49] Long-timescale molecular dynamics simulations elucidate the dynamics and kinetics of exposure of the hydrophobic patch in troponin C. , 2012, Biophysical journal.
[50] B. Sykes,et al. Structural based insights into the role of troponin in cardiac muscle pathophysiology , 2004, Journal of Muscle Research & Cell Motility.
[51] M. Nieminen,et al. Levosimendan: current data, clinical use and future development , 2013, Heart, lung and vessels.
[52] J. V. Van Eyk,et al. Altered interactions among thin filament proteins modulate cardiac function. , 1996, Journal of molecular and cellular cardiology.
[53] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[54] I. M. Robertson,et al. Interaction of cardiac troponin with cardiotonic drugs: a structural perspective. , 2008, Biochemical and biophysical research communications.
[55] Melonie P. Heron. Deaths: Leading Causes for 2017. , 2019, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[56] R. Adler,et al. Musculoskeletal system. , 2018, Ultrasound in medicine & biology.